Ruth Lopert

4

Articles

0

Comments
Protecting the patents of expensive medicines for longer would affect low-income countries. Jason Reed/ReutersPics

Time for costly medicine monopolies to go from TPP trade talks

Belinda Townsend, Australian National University; Deborah Gleeson, La Trobe University; Hazel Moir, Australian National University; Joel Lexchin, University of Sydney, and Ruth Lopert, George Washington University

Negotiators from 11 countries have been racing to resurrect the near-dead Trans-Pacific Partnership Agreement before the Asia-Pacific Economic Cooperation (APEC) summit this weekend.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached. EPA/Erik S. Lesser

Why biologics were such a big deal in the Trans Pacific Partnership

Ruth Lopert, George Washington University

Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
Trade minister Andrew Robb attends negotiations for the Trans Pacific Partnership in Sydney last year. Dan Himbrechts/AAP Image

How the battle over biologics helped stall the Trans Pacific Partnership

Deborah Gleeson, La Trobe University and Ruth Lopert, George Washington University

Over the next few weeks, the trade minister will be under intense pressure to renege on the government’s commitment to reject anything in the Trans Pacific Partnership that could undermine the PBS.
If the proposals are agreed, they could delay the market entry of generic medicines in the region – and the impact will be felt around the world. Jeng_Niamwhan

RCEP: the trade agreement you’ve never heard of but should be concerned about

Belinda Townsend, Deakin University; Deborah Gleeson, La Trobe University, and Ruth Lopert, George Washington University

Seven rounds of negotiations for the Regional Comprehensive Economic Partnership have already taken place with virtually no public debate. The next round of negotiations begins today in Kyoto, Japan.

Contact Ruth for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision